Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Albany Molecular Research Inc. and Sanofi-Aventis have settled lawsuits against Barr Pharmaceuticals and Teva Pharmaceutical Industries related to generic versions of fexofenadine HCl, sold by Sanofi as Allegra. Teva and Barr will each pay Sanofi about $30 million plus undisclosed future royalties. AMRI, the contract chemistry research firm that developed the route to the molecule, will get $10 million from Sanofi plus future royalties on fexofenadine products sold by all three firms.
This article has been sent to the following recipient: